Novo Nordisk publishes inaugural diversity and inclusion report with policies, progress and pursuits

Beth Snyder Bulik

Senior Editor

Novo Nordisk debuted its first diversity and inclusion report in North America this week laying out its commitments — and progress — for employees, patients and external …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Novo Nordisk publishes inaugural diversity and inclusion report with policies, progress and pursuits

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

Novo turns to Septerna for oral obesity medicines in deal worth up to $2.2B

Advocacy groups and experts call for decade-long ban on germline editing

TIGIT graveyard expands as GSK drops late-stage asset with iTeos

CRISPR patent spat revived by federal appeals court ruling

Some generics, biosimilar drugmakers say they can withstand tariff impact

No­vo Nordisk pub­lish­es in­au­gur­al di­ver­si­ty and in­clu­sion re­port with poli­cies, progress and pur­suits

Senior Editor

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Novo Nordisk publishes inaugural diversity and inclusion report with policies, progress and pursuits